Sign In to Follow Application
View All Documents & Correspondence
View All Documents & Correspondence
“Trans 4 [[(5 S) 5 [[[3&Nbsp;5 Bis(trifluoromethyl)phenyl]Methyl] (2 Methyl 2 H Tetrazol 5 Yl)amino] 2&Nbsp;3&Nbsp;4&Nbsp;5 Tetrahydro 7&Nbsp;9 Dimethyl 1 H 1 Benzazepin 1 Yl]Methyl] Cyclohexanecarboxylic Acid”
Abstract: Abstract Compounds of a formula entitled, trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2H-tetrazol- 5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]- cyclohexanecarboxylic acid, as a free acid or a pharmaceutically acceptable salt thereof, hydrate, and hydrate in crystalline form; pharmaceutical formulations; and methods of use are disclosed.
Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence
Notices, Deadlines & Correspondence
Patent Information
Application #
Filing Date
23 November 2011
Publication Number
05/2012
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Applicants
ELI LILLY AND COMPANY
Lilly Corporate Center Indianapolis Indiana 4628 United States of America
Inventors
1. Xinchao CHEN
Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana 4628 United States of America.
2. Scott Alan FRANK
Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana 4628 United States of America.
3. David Michael REMICK
Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana 46285 United States of America.
4. Steven Wayne PEDERSEN
Eli Lilly and Company Lilly Corporate Center Indianapolis Indiana 46285 United States of America.
Specification
PLEASE SEE THE SPECIFICATION ATTACHED
Documents
Application Documents
| # | Name | Date |
|---|---|---|
| 1 | 2474-MUMNP-2011-CORRESPONDENCE(IPO)-(FER)-(26-11-2014).pdf | 2014-11-26 |
| 2 | Petition Under Rule 137 [15-10-2015(online)].pdf | 2015-10-15 |
| 3 | 2474-MUMNP-2011-CORRESPONDENCE-(25-02-2016).pdf | 2016-02-25 |
| 4 | 2474-MUMNP-2011-CORRESPONDENCE-(13-04-2016).pdf | 2016-04-13 |
| 5 | 2474-MUMNP-2011-CORRESPONDENCE(IPO)-(DECISION)-(13-12-2016).pdf | 2016-12-13 |
| 7 | 2474-MUMNP-2011_EXAMREPORT.pdf | 2018-08-10 |
| 8 | 2474-MUMNP-2011-SPECIFICATION(AMENDED)-(31-8-2012).pdf | 2018-08-10 |
| 9 | 2474-MUMNP-2011-Power of Attorney-151214.pdf | 2018-08-10 |
| 10 | 2474-MUMNP-2011-OTHER DOCUMENT(7-4-2015).pdf | 2018-08-10 |
| 11 | 2474-MUMNP-2011-MARKED COPY-191015.pdf | 2018-08-10 |
| 12 | 2474-MUMNP-2011-MARKED COPY(31-8-2012).pdf | 2018-08-10 |
| 13 | 2474-MUMNP-2011-FORM PCT-ISA-237(5-7-2012).pdf | 2018-08-10 |
| 14 | 2474-MUMNP-2011-FORM PCT-IB-373(5-7-2012).pdf | 2018-08-10 |
| 15 | 2474-MUMNP-2011-FORM 3(7-4-2015).pdf | 2018-08-10 |
| 16 | 2474-MUMNP-2011-FORM 3(15-5-2012).pdf | 2018-08-10 |
| 18 | 2474-MUMNP-2011-FORM 13-(31-8-2012).pdf | 2018-08-10 |
| 19 | 2474-MUMNP-2011-FORM 13(5-12-2011).pdf | 2018-08-10 |
| 20 | 2474-MUMNP-2011-FORM 13(31-8-2012).pdf | 2018-08-10 |
| 21 | 2474-MUMNP-2011-FORM 1(31-8-2012).pdf | 2018-08-10 |
| 22 | 2474-MUMNP-2011-Examination Report Reply Recieved-191015.pdf | 2018-08-10 |
| 23 | 2474-MUMNP-2011-Correspondence-151214.pdf | 2018-08-10 |
| 24 | 2474-MUMNP-2011-CORRESPONDENCE(IPO)-(HEARING NOTICE)-(2-11-2016).pdf | 2018-08-10 |
| 25 | 2474-MUMNP-2011-CORRESPONDENCE(7-4-2015).pdf | 2018-08-10 |
| 26 | 2474-MUMNP-2011-CORRESPONDENCE(5-7-2012).pdf | 2018-08-10 |
| 27 | 2474-MUMNP-2011-CORRESPONDENCE(5-12-2011).pdf | 2018-08-10 |
| 28 | 2474-MUMNP-2011-CORRESPONDENCE(31-8-2012).pdf | 2018-08-10 |
| 29 | 2474-MUMNP-2011-CORRESPONDENCE(15-5-2012).pdf | 2018-08-10 |
| 30 | 2474-MUMNP-2011-CORRESPONDENCE(13-1-2012).pdf | 2018-08-10 |
| 31 | 2474-MUMNP-2011-Claims-191015.pdf | 2018-08-10 |
| 32 | 2474-MUMNP-2011-CLAIMS(MARKED COPY)-(5-12-2011).pdf | 2018-08-10 |
| 33 | 2474-MUMNP-2011-CLAIMS(AMENDED)-(31-8-2012).pdf | 2018-08-10 |
| 34 | 2474-MUMNP-2011-ASSIGNMENT(13-1-2012).pdf | 2018-08-10 |
| 35 | Form-5.pdf | 2021-10-03 |
| 36 | Form-3.pdf | 2021-10-03 |
| 37 | 2474-MUMNP-2011-CORRESPONDENCE(IPO)-(FER)-(26-11-2014).pdf | 2014-11-26 |
| 37 | Form-1.pdf | 2021-10-03 |